The consumer health industry in Asia is transforming in front of our eyes; unsurprisingly for a population of 4.5 billion and a kaleidoscope of cultures. Health marketers must reassess their approach and brands must shift to a proactive digital-first mindset.
Pharma marketing: get started on creating great customer experiences with journey strategies A well-defined customer journey strategy is critical to customer experience management (CEM) initiatives. Yet most pharmaceutical companies have […]
Closing the digital gap How pharma companies can benefit from digital advertising The shift of advertising dollars from billboards and traditional TV ads to online is nothing new. But one […]
Optimizing drug life cycle market performance Most drugs do not achieve their projected revenue forecasts. While revenue strategies for pharmacy dispensed drugs are well socialized, clinically administered drugs face unique, […]
SSCG Media Group shares findings from their most recent 2023 MAP MD survey results, which was designed to understand the next best evolution in the path to a successful media campaign.
Each year, Syneos Health takes stock of industry developments and harvests insights that can help shape a future of sustainable outcomes. If 2022 was a reset, 2023 is a year of renewal and re-imagining, where the senses are sharpened around what we need to learn.
EVERSANA INTOUCH’s annual trends paper looks ahead on the horizon in 2023 in pharma marketing.
The rise of consumerism has given patients more ownership of their care than ever before. And as consumer-facing technologies become commonplace, patients are increasingly shopping for healthcare experiences that align with their digital behaviors and preferences.
This paper explains the challenges patients face in traditional trial settings as well as how Aparito overcomes these challenges; how remote video is able to capture real-world evidence (RWE) while improving the patient experience; and how Aparito provides more meaningful patient data while protecting patient privacy.
A new position paper from noted thought leaders and the Association of Clinical Research Professionals provides the much-needed voice of the clinical trial professional.